Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT07370909 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07370909
- Sponsor
- Shanghai Longwood Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2028-03-31
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.